Drug resistance in glioblastoma: are persisters the key to therapy?

Glioblastoma (GBM) represents the main form of brain tumors in adults, and one of the most aggressive cancers overall. The treatment of GBM is a combination of surgery (when possible), chemotherapy (usually Temozolomide, TMZ) and radiotherapy (RT). However, despite this heavy treatment, GBM invariab...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Lisa, Lalier, Lisenn, Salaud, Céline, Heymann, Dominique, Cartron, Pierre François, Vallette, François M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992484/
https://www.ncbi.nlm.nih.gov/pubmed/35582442
http://dx.doi.org/10.20517/cdr.2020.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992484/
https://www.ncbi.nlm.nih.gov/pubmed/35582442
http://dx.doi.org/10.20517/cdr.2020.29

Ejemplares similares